These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11192006)

  • 1. Helminthic infection and HIV vaccine trials.
    Markus MB; Fincham JE
    Science; 2001 Jan; 291(5501):46-7. PubMed ID: 11192006
    [No Abstract]   [Full Text] [Related]  

  • 2. Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.
    Borkow G; Bentwich Z
    Clin Diagn Lab Immunol; 2002 May; 9(3):505-7. PubMed ID: 11986252
    [No Abstract]   [Full Text] [Related]  

  • 3. Eradication of helminthic infections may be essential for successful vaccination against HIV and tuberculosis.
    Borkow G; Bentwich Z
    Bull World Health Organ; 2000; 78(11):1368-9. PubMed ID: 11143198
    [No Abstract]   [Full Text] [Related]  

  • 4. How close is the AIDS vaccine?
    Wadman M
    Fortune; 2000 Nov; 142(11):277-8. PubMed ID: 11186834
    [No Abstract]   [Full Text] [Related]  

  • 5. Helminthes could influence the outcome of vaccines against TB in the tropics.
    Elias D; Akuffo H; Britton S
    Parasite Immunol; 2006 Oct; 28(10):507-13. PubMed ID: 16965286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mbeki and AIDS in Africa.
    Markus MB; Fincham JE
    Science; 2000 Jun; 288(5474):2131. PubMed ID: 10896582
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies.
    Chin'ombe N; Ruhanya V
    Pan Afr Med J; 2015; 20():386. PubMed ID: 26185576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulation by helminthic infections: worms and viral infections.
    Kamal SM; El Sayed Khalifa K
    Parasite Immunol; 2006 Oct; 28(10):483-96. PubMed ID: 16965284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates.
    Wille-Reece U; Flynn BJ; Loré K; Koup RA; Kedl RM; Mattapallil JJ; Weiss WR; Roederer M; Seder RA
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15190-4. PubMed ID: 16219698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against helminth parasite infections.
    Hewitson JP; Maizels RM
    Expert Rev Vaccines; 2014 Apr; 13(4):473-87. PubMed ID: 24606541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Tat-based vaccines: from basic science to clinical trials.
    Fanales-Belasio E; Cafaro A; Cara A; Negri DR; Fiorelli V; Butto S; Moretti S; Maggiorella MT; Baroncelli S; Michelini Z; Tripiciano A; Sernicola L; Scoglio A; Borsetti A; Ridolfi B; Bona R; Ten Haaft P; Macchia I; Leone P; Pavone-Cossut MR; Nappi F; Vardas E; Magnani M; Laguardia E; Caputo A; Titti F; Ensoli B
    DNA Cell Biol; 2002 Sep; 21(9):599-610. PubMed ID: 12396602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules.
    Fraternale A; Paoletti MF; Dominici S; Buondelmonte C; Caputo A; Castaldello A; Tripiciano A; Cafaro A; Palamara AT; Sgarbanti R; Garaci E; Ensoli B; Magnani M
    Vaccine; 2011 Sep; 29(40):6823-9. PubMed ID: 21816192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa.
    Jaspan HB; Gray GE; Robinson AK; Coovadia HM; Bekker LG
    S Afr Med J; 2005 Sep; 95(9):685-7. PubMed ID: 16327928
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing eosinophil count as a marker of immune activation among human immunodeficiency virus-infected persons in sub-Saharan Africa.
    Chorba TL; Nkengasong J; Roels TH; Monga B; Maurice C; Maran M; Djomand G
    Clin Infect Dis; 2002 May; 34(9):1264-6. PubMed ID: 11941554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV vaccine trials for Africa.
    AIDS Read; 2000 Sep; 10(9):524. PubMed ID: 11019443
    [No Abstract]   [Full Text] [Related]  

  • 16. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana.
    ; Osmanov S
    AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Africa boosts AIDS vaccine R&D.
    Cohen J
    Science; 2000 Jun; 288(5474):2165-7. PubMed ID: 10896604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First candidate enrolled in new HIV vaccine trial.
    Expert Rev Vaccines; 2003 Dec; 2(6):732-3. PubMed ID: 15278999
    [No Abstract]   [Full Text] [Related]  

  • 19. [Present situation, prevention and therapy of imported helminthic disease].
    Fujita K
    Nihon Rinsho; 1989 Jan; 47(1):118-22. PubMed ID: 2724555
    [No Abstract]   [Full Text] [Related]  

  • 20. Malaria endemicity and co-infection with tissue-dwelling parasites in Sub-Saharan Africa: a review.
    Onkoba NW; Chimbari MJ; Mukaratirwa S
    Infect Dis Poverty; 2015 Aug; 4():35. PubMed ID: 26377900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.